Person

Kathryn E. Wengel

EVP, Chief TO and Risk Officer, Johnson & Johnson

Current S&P 500 boards
1
Current roles
2
Open-market buys
$0
Open-market sales
$16.9M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Jun 11, 2026JNJSale10,000$241.15$2.4M
Jun 12, 2023JNJSale12,465$160.00$2.0M
Nov 9, 2022JNJSale16,410$173.42$2.8M
Jun 10, 2022JNJSale33,126$173.00$5.7M
Jun 10, 2022JNJSale6,600$173.00$1.1M
Jun 10, 2022JNJSale174$173.00$30K
Jun 10, 2022JNJSale100$173.00$17K
Sep 2, 2020JNJSale8,238$153.53$1.3M
Sep 2, 2020JNJSale7,877$153.51$1.2M
Dec 12, 2019JNJSale2,017$141.07$285K

SEC reporting-owner ID (CIK) 1745955 · all filings on EDGAR